Full Length Research Paper
References
|
Bradford PA (2001). Extended Spectrum β-lactamase in the 21st century: Characterization, epidemiology and detection of the important resistant threat. Clin. Microbiol. Rev. 14(4):933-952. |
|
|
Bush K (2001). New β-lactamase in gram negative bacteria: diversity and impact on selection antimicrobial therapy. Clin. Infect. Dis. 32:1085-1089. |
|
|
Cheesbrough M (2004). District Laboratory Practice for Tropical Countries (part 2). Cambridge University Press, UK. pp. 180 - 197. |
|
|
David LW, Frank GR (2000). Surveillance of antimicrobial resistance in Salmonella, Shigella and Vibrio cholerae in Latin America and the Caribbean: A collaborative project. Can. J. Infect. Dis. 11 (4): 181 - 186. |
|
|
Gyansa-Lutterodt M (2013). Antibiotic Resistance in Ghana. Lancet Infect. Dis. 13: 1006 – 1007. |
|
|
Irajian G, Ranjbar RA, Moghadas AJ (2009). Detection of Extended Spectrum β-lactamase producing Salmonella species and multidrug resistance pattern. Iran. J. Pathol. 4 (3): 128 - 132. |
|
|
Kotra LP, Samama J, Mobashery S (2007). Beta-lactamases and resistance to beta-lactam antibiotics In: Lewis K, Salyers AA, Taber HW, Wax RG, eds. Bacterial Resistance to Antimicrobials. New York Marcel Decker: 123 - 160. |
|
|
Livermore DM, Brown DF (2001). Detection of β-lactamase medical resistance. J. Antimicrob. Chemother. 48 : 59 - 64. |
|
|
Marchandin H, Carriere C, Sirot D, Pierre HJ, Darbas H (1999). TEM-2 produced by four different species of enterobacteriaceae including providencia rettgeri, in a single patient. Antimicrob. Agents Chemother. 43:2069-2073. |
|
|
Medeiros AA (1997). Evolution and dissemination of β-lactamase accelerated by generations of β-lactam antibiotics. Clin. Infect. Dis. 24 (1):19-45. |
|
|
Obeng-Nkurumah N, Krogfelt KA, Newman MJ (2013). High levels of Extened-Spectrum Beta-lactamases in a major teaching hospital in Ghana: the need for regular monitoring and evaluation of antibiotic resistance. Am. J. Trop. Med. Hyg. 89(5):960-964. |
|
|
Paterson DL, Bronomo RA (2005). Extended-spectrum beta-Lactamases: a clinical update. Clin. Microbiol. Rev. 18 (4): 657 - 687. |
|
|
Rodríguez MM, Power P, Radice M, Vay C, Famiglietti A, Galleni M, Ayala JA, Gutkind G (2004). Chromosome-encoded CTX-M-3 from Kluyvera ascorbata: a possible origin of plasmid-borne CTX-M-1-derived Cefotaximases. Antimicrob. Agents Chemother. 48:4895 - 4897. |
|
|
Spanu T, Luzzaro F, Perilli M, Amicosante G, Toniolo A, Fadda G (2002). Occurrence of extended- spectrum beta lactamases in members of the family Enterobacteriaceae in Italy: implications for resistance to beta-lactams and other antimicrobial drugs. Antimicrob. Agents Chemother. 46:196 - 202. |
|
|
Uma B, Prabhakar K, Rajendran S, Sarayu YL (2010). Prevalence of Extended Spectrum Beta lactamases in Salmonella species isolated from patients with acute gastroenteritics. Indian J. Gastroenterol. 29: 201 – 204. |
|
|
Valverde A, Grill F, Teresa MC, Pintado V, Fernando B, Rafael C, Cobo J (2008). High rate of intestinal colonization with extended-spectrum-lactamase-producing organisms in household contacts of infected community patients. J. Clin. Microbiol. 46 (8):2796 - 2799. |
|
|
Yusha M, Aliyu HM, Kumurya AS, Suleiman K (2010). Prevalence of Extended spectrum β-lactamases (ESBLs) among Enterobacteriacea in Murtala Mohammed specialist Hospital, Kano, Nigeria. Bayero J. Pure Appl. Sci. 3(1):169 - 172. |
|
|
Zaki MES (2007). Extended spectrum β-lactamases among gram-negative bacteria from an Egyptian pediatric hospital: a two-year experience. J. Infect. Dev. Ctries. 1 (3):269 - 274. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
